The peptide underwent testing for its potential advantages in patients suffering from post-surgical ileus, a condition related to lack of peristalsis manifesting after gastrointestinal surgery
doi:10.1016/j.jad.2011.06.005 Farokhnia M, Azarkolah A, Adinehfar F, Khodaie-Ardakani MR, Hosseini SM, Yekehtaz H, Tabrizi M, Rezaei F, Salehi B, Sadeghi SM, Moghadam M, Gharibi F, Mirshafiee O, Akhondzadeh S (2013) N -acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study
Cancer Biol Med
The implementation of the EU Health Technology Assessment (HTA) Regulation is increasing the focus on patient-centered outcomes and real-world evidence to complement clinical trial data in reimbursement and access decision-making